FRNM Stock Analysis

Freenome, Inc. Common Stock (FRNM): A Detailed Educational Review

Overview of Freenome, Inc. Common Stock (FRNM)

Freenome, Inc. (FRNM) is a healthcare company operating in the diagnostics and research industry. This StockValueFinder educational review examines the available financial metrics for FRNM to help investors understand how to evaluate stocks using fundamental and valuation discipline. The goal is to provide clear, factual analysis—not personal financial advice or predictions about future performance.

At the time of this review, FRNM has a StockValueFinder score of 50% and an overall rating of **AVOID**. This rating reflects a mixed financial profile with both strengths and significant weaknesses. The recent stock price is $14.58, and the available metrics include a negative P/E ratio, a strong return on invested capital (ROIC), and an unusual debt payback figure. Below, we break down each key metric to explain what it means, why it matters, and how FRNM performs relative to typical benchmarks.

Why the StockValueFinder Score Matters

The StockValueFinder score is a composite measure designed to help investors assess a stock’s financial health and valuation discipline. It ranges from 0% to 100%, with higher scores indicating stronger fundamentals and more attractive valuations. A score of 50% suggests that FRNM meets some—but not all—of the criteria for a high-quality stock.

The **AVOID** rating does not mean the company is failing or that the stock will decline. Instead, it signals that the current financial profile does not meet the conservative standards used in this screening system. Investors should carefully weigh the strengths and weaknesses before making any decisions.

The score is based on five key tests

1. **Earnings Per Share (EPS) strength** 2. **Return on Invested Capital (ROIC)** 3. **Interest coverage** 4. **Debt payback years** 5. **Price-to-Earnings (P/E) ratio**

Each test is explained in detail below.

EPS Strength and Consistency

What EPS Measures

Earnings per share (EPS) measures a company’s profitability on a per-share basis. Consistent or growing EPS over time is generally a sign of a stable, well-managed business. StockValueFinder looks for companies with a track record of positive and predictable earnings, as this reduces the risk of unexpected financial trouble.

Typical Ranges

FRNM’s EPS Test Result

The system recorded that FRNM **did not pass** the EPS test. This means the company does not meet the criteria for consistent or positive earnings over the evaluated period. **Exact EPS values were not supplied**, so we cannot analyze specific quarterly or annual figures. However, the failure of this test suggests that FRNM has either reported losses or has not demonstrated the earnings stability preferred by this screening system.

Why This Matters

Companies with weak or negative EPS often face higher financial risk. They may struggle to fund operations, invest in growth, or service debt without relying on external financing. For example, a company with EPS of $0.50 in Year 1, -$0.20 in Year 2, and $0.10 in Year 3 would likely fail this test due to the loss in Year 2. In contrast, a company with EPS of $1.00, $1.10, and $1.20 over three years would pass, as it shows steady profitability.

ROIC and Capital Efficiency

What ROIC Measures

Return on Invested Capital (ROIC) measures how efficiently a company uses its capital to generate profits. It answers the question: *For every dollar invested in the business, how much profit does the company generate?* A high ROIC suggests strong management and a competitive advantage, while a low ROIC may indicate poor capital allocation or weak market positioning.

Typical Ranges

FRNM’s ROIC

FRNM’s ROIC is **18.90%**, which is well above the 10% threshold. This means the company is generating nearly 19 cents of profit for every dollar of invested capital.

Why FRNM Passed This Test

A ROIC of 18.90% is strong by most standards. For comparison

Limitations of ROIC

While ROIC is a useful metric, it does not tell the whole story. For example

Interest Coverage and Financial Safety

What Interest Coverage Measures

Interest coverage measures a company’s ability to pay the interest on its debt. It is calculated as: **Interest Coverage = Earnings Before Interest and Taxes (EBIT) / Interest Expense**

A higher ratio indicates greater financial safety, as the company can easily cover its interest obligations. A low or negative ratio suggests the company may struggle to service its debt, increasing the risk of default.

Typical Ranges

FRNM’s Interest Coverage Test Result

The system recorded that FRNM **did not pass** the interest coverage test. **Exact interest coverage values were not supplied**, so we cannot analyze the specific ratio. However, the failure of this test suggests that FRNM’s earnings are insufficient to comfortably cover its interest expenses.

Why This Matters

Companies with weak interest coverage are more vulnerable to financial stress, especially if interest rates rise or earnings decline. For example: - A company with interest coverage of 8x can easily pay its interest obligations, even if earnings dip temporarily. - A company with interest coverage of 1.5x may struggle to make payments if cash flow weakens, increasing the risk of default.

Debt Payback and Balance Sheet Discipline

What Debt Payback Measures

Debt payback years estimate how long it would take a company to pay off its total debt using its current operating income. It is calculated as: **Debt Payback Years = Total Debt / (EBIT - Taxes)**

A shorter payback period indicates a stronger balance sheet, while a longer period suggests higher financial risk.

Typical Ranges

FRNM’s Debt Payback

FRNM’s debt payback years are **-0.78**. This negative value is unusual and suggests that the company’s operating income is not sufficient to cover its debt obligations under standard calculations. In most cases, a negative debt payback figure indicates that the company is generating losses or has minimal earnings relative to its debt load.

Why FRNM Passed This Test

Despite the negative figure, the system recorded that FRNM **passed** the debt payback test. This is likely because the screening system accounts for edge cases, such as companies in high-growth industries (e.g., biotech) that may prioritize reinvestment over debt repayment. However, investors should interpret this result with caution, as a negative debt payback is generally a red flag.

Why This Matters

Debt payback is a critical measure of financial health. For example

P/E Ratio and Valuation Discipline

What P/E Ratio Measures

The price-to-earnings (P/E) ratio measures how much investors are willing to pay for each dollar of a company’s earnings. It is calculated as: **P/E Ratio = Stock Price / Earnings Per Share (EPS)**

A lower P/E ratio may indicate a more attractively valued stock, while a higher P/E ratio suggests investors are paying a premium for future growth.

Typical Ranges

FRNM’s P/E Ratio

FRNM’s P/E ratio is **-922.78**. This negative value occurs because the company is reporting losses (negative EPS), making the P/E ratio meaningless in the traditional sense. However, the system recorded that FRNM **passed** the P/E valuation test, likely because the screening system does not penalize companies with negative P/E ratios if they operate in industries where losses are common during growth phases (e.g., biotech, early-stage tech).

Why This Matters

The P/E ratio is a useful tool for comparing stocks within the same industry. For example: - A company with a P/E of 8 may be more attractively valued than a peer with a P/E of 30, assuming similar growth prospects. - However, a negative P/E ratio provides no insight into valuation, as it simply reflects current losses.

Moving Average Trend and Entry Timing

What Moving Averages Measure

Moving averages smooth out price fluctuations to identify trends. StockValueFinder uses moving averages to assess whether a stock is in an uptrend, downtrend, or trading sideways. This is not a prediction of future performance but rather a tool for timing discipline.

FRNM’s Moving Average Signal

The system recorded **INSUFFICIENT DATA** for FRNM’s moving average signal. This means there is not enough historical price data to determine a trend. Additionally, the **entry signal** and **entry status** are marked as **N/A**, indicating that no actionable trend signal is available.

Why This Matters

Moving averages are useful for identifying potential entry or exit points. For example

Without sufficient data, investors cannot rely on trend analysis for FRNM.

Overall Financial Strengths and Weaknesses

Strengths

1. **Strong ROIC (18.90%)**: FRNM is generating solid returns on its invested capital, suggesting efficient use of resources. 2. **Passed Debt Payback Test**: Despite the negative figure, the system did not flag this as a failure, possibly due to industry-specific considerations. 3. **Passed P/E Valuation Test**: The negative P/E ratio was not penalized, likely because the company operates in a sector where losses are common during growth phases.

Weaknesses

1. **Failed EPS Test**: The lack of consistent or positive earnings is a significant risk factor. 2. **Failed Interest Coverage Test**: The company’s earnings are insufficient to comfortably cover its interest obligations, increasing financial risk. 3. **Negative Debt Payback (-0.78 years)**: This unusual figure suggests the company’s operating income is not sufficient to service its debt under standard calculations. 4. **Insufficient Trend Data**: Without a clear moving average signal, investors cannot rely on trend analysis for timing decisions.

Risks and Limitations

1. **Earnings Risk**: FRNM’s failure of the EPS test indicates a history of losses or inconsistent profitability. This increases the risk of financial instability, especially if the company cannot achieve sustained profitability. 2. **Debt Risk**: The negative debt payback figure and failure of the interest coverage test suggest that FRNM’s debt load may be unsustainable without improved earnings or additional financing. 3. **Valuation Risk**: The negative P/E ratio provides no insight into the stock’s valuation, making it difficult to assess whether the current price is reasonable. 4. **Industry Risk**: Companies in the diagnostics and research industry often face long development cycles, regulatory hurdles, and high R&D costs. These factors can delay profitability and increase financial risk. 5. **Data Limitations**: The lack of detailed EPS history, interest coverage ratio, and moving average data limits the depth of this analysis. Investors should seek additional information before making decisions.

Educational Conclusion

This review of Freenome, Inc. Common Stock (FRNM) demonstrates how to evaluate a stock using fundamental and valuation metrics. While FRNM shows strength in its **ROIC (18.90%)**, it faces significant challenges in **EPS consistency, interest coverage, and debt payback**. The StockValueFinder score of 50% and **AVOID** rating reflect these mixed results.

Key Takeaways for Investors

1. **ROIC is a strength**: FRNM’s 18.90% ROIC suggests efficient capital use, but investors should confirm whether this is sustainable. 2. **Earnings and debt are weaknesses**: The failure of the EPS and interest coverage tests, along with the negative debt payback figure, indicate higher financial risk. 3. **Valuation is unclear**: The negative P/E ratio provides no insight into whether the stock is attractively priced. 4. **Trend analysis is unavailable**: Without sufficient moving average data, investors cannot rely on trend signals for timing decisions.

How to Apply This Analysis to Other Stocks

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.

Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings